Wearable monitoring of motor development in babies and young children with spinal muscular atrophy detected at birth
Official title: A Prospective, Longitudinal and Decentralised Study Investigating the Motor Development of Patients With Spinal Muscular Atrophy Identified by Newborn Screening Age 4 Years and Below: Active-NBS UK.
Run by University of Oxford · NCT07543003 · Data updated 2026-11-12
This project will try wearing small motion sensors at home to see if they can track how babies and young children diagnosed with spinal muscular atrophy at birth move and develop, compared with healthy children.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 4 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | July 31, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07543003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are infants and young children (from before 4 months up to under 4 years) with genetically confirmed SMA and known SMN2 copy number, identified by newborn screening or family diagnosis, whose parents can provide consent and who are not enrolled in another experimental treatment study.
✕Probably not a fit
Children older than 4 years, those with acute or chronic conditions that significantly interfere with motor assessments, or those currently in experimental treatment trials are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, longitudinal effort will follow up to 60 children identified with SMA (and healthy controls) for as long as 30 months using home-worn wearable devices (Syde and Motor Assessment) to capture motor activity. Participants will include infants and children from before 4 months up to under 4 years of age, with known SMN2 copy number and variable exposure to disease-modifying therapies. Data will be collected remotely through a federated model and analyzed to validate motor outcome measures suitable for this young age group. The goal is to determine when movement patterns diverge from typical development to inform timing of additional treatments under development.
Why it matters
Potential benefit: If successful, the work could provide reliable home-based measures of early motor change that help clinicians decide when to give extra therapies to support muscle development.
How similar studies have gone: Wearable monitoring approaches have shown promise in older children and adults with neuromuscular disease, but remote longitudinal monitoring specifically in newborn-detected SMA is relatively novel and only partially validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria (Test cohort): 1. Genetically confirmed SMA and number of SMN2 copies available 2. a. Patients identified by NBS and treated with disease modifying therapy (DMT) (2)a,i 4 copies or more of SMN2 and not treated with DMT (2)a,ii less than 4 copies of SMN2 and not treated with DMT or (2)b. Patients diagnosed due to a sibling or alternative means (2)b,i 4 copies or more of SMN2 and not treated with DMT (2)b,ii less than 4 copies of SMN2 and not treated with DMT (3)Patients between 4 months and below 4 years at baseline. Inclusion of patients can be before 4 months of age (4)Parent(s)/legal guardian(s) able to provide written informed consent prior to the patient's participation in the study Exclusion Criteria (Test cohort): (1) Any acute or chronic condition which, according to the investigator, significantly interferes with the assessments and/or the motor evolution Inclusion criteria (Control): 1. Typically developing child 2. Participant between 6 months and 4 years at baseline 3. Parent(s)/legal guardian(s) able to provide written informed consent prior to the participation in the study Exclusion criteria (Control): (1)Any acute or chronic condition which, according to the investigator, significantly interferes with the assessments and/or the motor evolution
Where it's running
-
University of Oxford
Oxford, United Kingdom Recruiting
Study contacts
- Study coordinator: Charlotte Lilien
- Email: charlotte.lilien@paediatrics.ox.ac.uk
- Phone: 01865618799
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn SMA Screening Service Evaluation
This project tests newborn SMA screening to see if it works well and is acceptable to families in the UK.
-
Biomarker search in SMA using advanced multi-omics
Researchers are trying to see if new biomarkers can help diagnose and monitor spinal muscular atrophy in patients and newborns.
-
Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
This study tests whether a portable knee-training robot with a compliant vs. rigid stiffness setting improves knee strength in children with spinal muscular atrophy, using each child’s other leg as a comparison.
-
HABIT-ILE plus Functional Strength Training for Children with SMA
This study will try an intensive HABIT-ILE program combined with functional strength training for children aged 5–17 with SMA who are on stable disease-modifying therapy to see if it improves motor skills.
-
Long-read genetic analysis for Spinal Muscular Atrophy (LOREASI)
This project tries a long-read DNA technique on adults with known SMN1 copy-number patterns to find hidden '2+0' carrier genotypes that standard tests miss.
-
Portable markerless video system to measure walking in adults with neuromuscular conditions or healthy volunteers.
This project will test a portable video device that measures walking patterns to see if it can track gait changes in adults with neuromuscular diseases and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.